{"data":[{"accessionNo":"0000905148-26-002432","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001478320","issuerName":"Adaptive Biotechnologies Corp","ticker":"ADPT","cusip":"00650F109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"VIKING GLOBAL INVESTORS LP","reportingCik":null,"personType":"PN","sharesOwned":29993708,"percentOfClass":18.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/adpt"},{"accessionNo":"0000905148-26-002432","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001478320","issuerName":"Adaptive Biotechnologies Corp","ticker":"ADPT","cusip":"00650F109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"HALVORSEN OLE ANDREAS","reportingCik":null,"personType":"IN","sharesOwned":29993708,"percentOfClass":18.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/adpt"},{"accessionNo":"0000905148-26-002432","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001478320","issuerName":"Adaptive Biotechnologies Corp","ticker":"ADPT","cusip":"00650F109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Shabet Rose Sharon","reportingCik":null,"personType":"IN","sharesOwned":29993708,"percentOfClass":18.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/adpt"},{"accessionNo":"0000905148-26-002432","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001478320","issuerName":"Adaptive Biotechnologies Corp","ticker":"ADPT","cusip":"00650F109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"VIKING GLOBAL PERFORMANCE LLC","reportingCik":null,"personType":"OO","sharesOwned":22002189,"percentOfClass":13.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/adpt"},{"accessionNo":"0000905148-26-002432","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001478320","issuerName":"Adaptive Biotechnologies Corp","ticker":"ADPT","cusip":"00650F109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Equities Master Ltd.","reportingCik":null,"personType":"CO","sharesOwned":21562143,"percentOfClass":13.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/adpt"},{"accessionNo":"0000905148-26-002432","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001478320","issuerName":"Adaptive Biotechnologies Corp","ticker":"ADPT","cusip":"00650F109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Viking Long Fund Master Ltd.","reportingCik":null,"personType":"CO","sharesOwned":7991519,"percentOfClass":5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/adpt"},{"accessionNo":"0000905148-26-002432","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001478320","issuerName":"Adaptive Biotechnologies Corp","ticker":"ADPT","cusip":"00650F109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Viking Long Fund GP LLC","reportingCik":null,"personType":"OO","sharesOwned":7991519,"percentOfClass":5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/adpt"},{"accessionNo":"0000905148-26-002432","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001478320","issuerName":"Adaptive Biotechnologies Corp","ticker":"ADPT","cusip":"00650F109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Equities II LP","reportingCik":null,"personType":"PN","sharesOwned":440046,"percentOfClass":0.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/adpt"},{"accessionNo":"0000102909-26-000534","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001478320","issuerName":"Adaptive Biotechnologies Corp","ticker":"ADPT","cusip":"00650F109","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/adpt"},{"accessionNo":"0002012383-26-000632","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001478320","issuerName":"Adaptive Biotechnologies Corp","ticker":"ADPT","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":11992448,"percentOfClass":7.9,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/adpt"}],"updatedAt":"2026-10-29T09:07:07.248Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/adpt","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}